NuAge Technologies Information

NuAge Technologies provides hands-on operational and strategic consultancy for medical device and biotech companies at the stages where it matters most — getting from promising science to a market-ready, investor-credible product. Founded by Wayne Jensen PhD, NuAge brings over 30 years of direct experience in medtech and biotech product development — not advisory experience, but actual bench-level R&D, manufacturing scale-up, regulatory submissions, and executive leadership across companies including Universal Biosensors, INOVIQ (ASX: IIQ), Vitrafy Life Sciences, Trace Scientific, Thermo Fisher, Wavewise Analytics and Apop Biosciences. Wayne has personally been involved in bringing more than 25 products to domestic and international markets. What NuAge does: → Product R&D leadership — from technology assessment and feasibility through to design freeze and verification → Capital raise and investor readiness — building the technical credibility and operational roadmaps that survive due diligence → ISO 13485 quality system implementation and design control → TGA, FDA 510(k), and CE/MDR regulatory strategy and submission support → cGMP manufacturing setup — in-house and CDMO → Fractional COO/CSO for companies that need senior operational capability without a full-time hire → Productised regulatory writing — fixed-fee CER, 510(k), Pre-Sub, IVDR PER and PMPF (post market performance follow-up) documentation for medtech and IVD SMEs that need a specific document rather than a full operational engagement. Every engagement is led personally by Wayne Jensen. No junior consultants, no delegation after the pitch. Who NuAge works with: Medical device and biotech startups and scaling companies — from pre-seed through to post-IPO — that need to move faster, raise capital, and get to market. Learn more and get in touch: nuage-technologies.com